86639-52-3 Purity
98%
If you have any other questions or need other size, please get a quote.
Specification
Total thyroxine (TT4) is labeled with DMAE·NHS [2',6'-dimethyl-4'-(n-succinimidyloxycarbonyl) phenyl-10-methyl-acridinium-9-carboxylate methosulfate] acridinium ester, allowing rapid and sensitive determination of TT4 by chemiluminescence immunoassay (CLIA). In this CLIA procedure, microwells were coated with anti-T4 monoclonal antibody (McAb) and streptavidin (SA) was conjugated with DMAE·NHS. Biotin-N-hydroxysuccinimide (B·NHS) was used to conjugate T4-BSA, and in a competitive reaction with anti-T4 McAb, T4-BSA-B·NHS and the T4 in the standard or sample were involved.
Preparation of DMAE·NHS-SA
· A 2 mL brown glass bottle was used to mix 90 mg SA, 200 mL labeling buffer, and 10.5 mL of the 6.5 mmol/L DMAE·NHS solution. Following a 2-hour incubation at room temperature, the reaction was stopped by adding 100 mL of 10 g/L lysine and allowing it to sit at room temperature for 15 minutes.
· The unreacted DMAE·NHS was isolated from the conjugate of DMAE·NHS-SA using size-exclusion chromatography on a 1×25-cm column, with elution performed using a purifying buffer while monitoring the protein peak at 280 nm with a high-pressure liquid chromatograph.
· Chemiluminescence intensity and protein concentration were assessed on a Multilabel Counter and UV-Visible Spectrophotometer, respectively. Fractions exhibiting high chemiluminescence intensity and protein concentration were combined and preserved at -20°C after the addition of 1% BSA.